- Home
- ZEPP vs ICAD Comparison
ZEPP vs ICAD Comparison
Compare ZEPP & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- ICAD
- Stock Information
- Founded
- ZEPP 2013
- ICAD 1984
- Country
- ZEPP China
- ICAD United States
- Employees
- ZEPP N/A
- ICAD N/A
- Industry
- ZEPP Computer Manufacturing
- ICAD Medical/Dental Instruments
- Sector
- ZEPP Technology
- ICAD Health Care
- Exchange
- ZEPP Nasdaq
- ICAD Nasdaq
- Market Cap
- ZEPP 48.8M
- ICAD 40.8M
- IPO Year
- ZEPP N/A
- ICAD 1986
- Fundamental
- Price
- ZEPP $2.91
- ICAD $2.06
- Analyst Decision
- ZEPP
- ICAD
- Analyst Count
- ZEPP 0
- ICAD 0
- Target Price
- ZEPP N/A
- ICAD N/A
- AVG Volume (30 Days)
- ZEPP 12.0K
- ICAD 219.1K
- Earning Date
- ZEPP 11-18-2024
- ICAD 11-13-2024
- Dividend Yield
- ZEPP N/A
- ICAD N/A
- EPS Growth
- ZEPP N/A
- ICAD N/A
- EPS
- ZEPP N/A
- ICAD N/A
- Revenue
- ZEPP $208,946,095.00
- ICAD $18,940,000.00
- Revenue This Year
- ZEPP N/A
- ICAD $10.15
- Revenue Next Year
- ZEPP $18.94
- ICAD $3.75
- P/E Ratio
- ZEPP N/A
- ICAD N/A
- Revenue Growth
- ZEPP N/A
- ICAD 10.03
- 52 Week Low
- ZEPP $2.06
- ICAD $1.18
- 52 Week High
- ZEPP $8.40
- ICAD $2.65
- Technical
- Relative Strength Index (RSI)
- ZEPP 50.54
- ICAD 60.60
- Support Level
- ZEPP $2.53
- ICAD $1.82
- Resistance Level
- ZEPP $3.10
- ICAD $1.90
- Average True Range (ATR)
- ZEPP 0.22
- ICAD 0.16
- MACD
- ZEPP 0.01
- ICAD 0.02
- Stochastic Oscillator
- ZEPP 65.79
- ICAD 81.63
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.